Hung Ong, MD
MOHS-Micrographic Surgery · Newport Beach, CANPI 1407842149
Payments from drug & device makers
Across 173 payments — averaging $25.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Pfizer$684
- Sanofi$370
- Incyte Corporation$242
- Novartis$229
- AstraZeneca$125
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,360100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 65 | $1,606 |
| Pfizer | 43 | $684 |
| Sanofi | 7 | $370 |
| Incyte Corporation | 9 | $242 |
| Novartis | 10 | $229 |
| AstraZeneca | 1 | $125 |
| Covidien LP | 1 | $124 |
| Amgen | 6 | $123 |
| Gilead | 1 | $123 |
| Sun Pharmaceutical Industries Inc. | 5 | $119 |
| Endogastric Solutions, Inc | 1 | $116 |
| Galderma Laboratories, L.p. | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| LEO Pharma Inc. | 2 | $58 |
| UCB, Inc. | 2 | $49 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $42 |
| Biofrontera Inc. | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 1 | $31 |
| Revance Therapeutics, Inc. | 2 | $29 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Misonix Inc | 1 | $14 |
| Strata Skin Sciences, Inc. | 1 | $14 |
| Bard Peripheral Vascular, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,360 in reported general payments places this provider in the 60th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 36 | $2,691 |
| Triamcinolone Acetonide | 134 | $1,737 |
| Minoxidil | 116 | $1,364 |
| Doxycycline Hyclate | 42 | $1,261 |
| Tretinoin | 17 | $1,204 |
| Fluorouracil | 16 | $1,172 |
| ValacyclovirValacyclovir Hcl | 23 | $1,153 |
| Ciclopirox | 17 | $408 |
| Ketoconazole | 16 | $354 |
| Betamethasone Dipropionate | 11 | $324 |
| Hydrocortisone | 52 | $285 |
| Hydroxyzine Hcl | 12 | $284 |
| Fluconazole | 22 | $229 |
| Mupirocin | 29 | $191 |
| Spironolactone | 12 | $125 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Newport Beach
- Grace LiuNewport Beach$10K
- Adam RotundaNewport Beach$8K
- Anne Marie McNeillNewport Beach$7K
- Gregory HendersonNewport Beach$4K
- Michael MortazieOrange$1.2M
- Thuzar ShinSacramento$353K
- Sarah ArronBurlingame$223K
- Christopher Crosbyla Mesa$211K
- Abel TorresLoma Linda$136K
- Robert ScheinbergOceanside$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.